Biopharma Leaders To Gather At MIT For Longwood Healthcare Spring Forum

Longwood Fund, an early-stage life science venture firm, will convene top biopharmaceutical leaders for two days of discussion and networking at its annual Longwood Healthcare Leaders Spring MIT forum. The event, co-hosted by Koch Institute Professors Phil Sharp and Bob Langer, will be held at MIT’s Koch Institute on June 17-18, 2024.

The forum will focus on a broad spectrum of topics affecting the biopharma ecosystem. Decision-makers in the life sciences, including biopharma CEOs, research and development heads, leading academics, and investors, will discuss some of the most important issues facing healthcare today.

Hosted by Longwood Fund, industry leaders will speak in curated fireside chats and discussion panels. Notable speakers include Sally Kornbluth (President, MIT), Phil Sharp (Co-Founder, Alnylam, Biogen), Bob Langer (Co-Founder, Moderna), Peter Marks (Director, CBER, FDA), Jake Auchincloss (U.S. Representative), and Rochelle Walensky (former Director, CDC).

Other prominent figures such as Chris Viehbacher (CEO, Biogen), Christophe Weber (CEO, Takeda), Mikael Dolsten (CSO & President, R&D, Pfizer), Andy Plump (President, R&D, Takeda), Anne Klibanski (CEO, Mass General Brigham), Dave Reese (CTO, Amgen), Mathai Mammen (CEO, FogPharma), Marianne De Backer (CEO, Vir Biotechnology), and Sek Kathiresan (CEO, Verve) will also participate.

The forum encourages open dialogue with a C-suite audience asking questions throughout discussions. This leads to actionable takeaways and business development opportunities. Topics include driving early-stage innovation and entrepreneurship, R&D collaboration, identifying next-generation therapeutics, innovation in drug discovery, big biopharma pipeline sourcing, targeted licensing and acquisitions.

Additional subjects cover the future of mental healthcare, navigating partnerships across borders, getting to regulatory approval, advancing late-stage assets, ensuring health equity and access, and developing a strong syndicate. Networking opportunities are built into the agenda with luncheons, breakfasts, and a cocktail reception on June 17.

About Longwood Fund

Longwood Fund is a venture capital firm dedicated to creating and investing in novel healthcare companies that develop important treatments to help patients while generating significant value for investors. The Longwood team has a long history of launching and building important life science companies while providing operational leadership and strategic guidance.

Collectively, the Partners at Longwood have co-founded 25 companies with over 20 launched or marketed therapies and more than two dozen clinical assets. Companies founded by Longwood or its principals prior to the founding of the firm include Acceleron, Momenta, Alnylam, Vertex, Sirtris, Vor BioPharma, TScan Therapeutics, Pyxis Oncology.

Longwood Healthcare Leaders

Longwood Healthcare Leaders hosts industry conferences with thought leaders, key executives, and government officials for quarterly forums at institutions including MIT, Harvard University, and Stanford University. These meetings aim to foster collaboration and exchange insights to drive biomedical advancements from the top.

For more information about the event or to register: www.longwoodhealthcareleaders.com/spring2024

For more information about Longwood Fund: www.longwoodfund.com